» Articles » PMID: 12531894

Proteome Analysis Reveals Phosphorylation of ATP Synthase Beta -subunit in Human Skeletal Muscle and Proteins with Potential Roles in Type 2 Diabetes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Jan 18
PMID 12531894
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin resistance in skeletal muscle is a hallmark feature of type 2 diabetes. An increasing number of enzymes and metabolic pathways have been implicated in the development of insulin resistance. However, the primary cellular cause of insulin resistance remains uncertain. Proteome analysis can quantitate a large number of proteins and their post-translational modifications simultaneously and is a powerful tool to study polygenic diseases like type 2 diabetes. Using this approach on human skeletal muscle biopsies, we have identified eight potential protein markers for type 2 diabetes in the fasting state. The observed changes in protein expression indicate increased cellular stress, e.g. up-regulation of two heat shock proteins, and perturbations in ATP (re)synthesis and mitochondrial metabolism, e.g. down-regulation of ATP synthase beta-subunit and creatine kinase B, in skeletal muscle of patients with type 2 diabetes. Phosphorylation appears to play a key, potentially coordinating role for most of the proteins identified in this study. In particular, we demonstrated that the catalytic beta-subunit of ATP synthase is phosphorylated in vivo and that the levels of a down-regulated ATP synthase beta-subunit phosphoisoform in diabetic muscle correlated inversely with fasting plasma glucose levels. These data suggest a role for phosphorylation of ATP synthase beta-subunit in the regulation of ATP synthesis and that alterations in the regulation of ATP synthesis and cellular stress proteins may contribute to the pathogenesis of type 2 diabetes.

Citing Articles

Early postmortem beef muscle proteome and metabolome variations due to supranutritional zinc and ractopamine hydrochloride supplementation.

Schulte M, Hochmuth K, Steadham E, Lonergan S, Hansen S, Huff-Lonergan E J Anim Sci. 2024; 102.

PMID: 39279203 PMC: 11491740. DOI: 10.1093/jas/skae272.


mtDNA Single-Nucleotide Variants Associated with Type 2 Diabetes.

Garcia-Gaona E, Garcia-Gregorio A, Garcia-Jimenez C, Lopez-Olaiz M, Mendoza-Ramirez P, Fernandez-Guzman D Curr Issues Mol Biol. 2023; 45(11):8716-8732.

PMID: 37998725 PMC: 10670651. DOI: 10.3390/cimb45110548.


Mitochondrial heterogeneity in diseases.

Chen L, Zhou M, Li H, Liu D, Liao P, Zong Y Signal Transduct Target Ther. 2023; 8(1):311.

PMID: 37607925 PMC: 10444818. DOI: 10.1038/s41392-023-01546-w.


Differences in protein expression, at the basal state and at 2 h of insulin infusion, in muscle biopsies from healthy Arab men with high or low insulin sensitivity measured by hyperinsulinemic euglycemic clamp.

Bettahi I, Krishnankutty R, Jaganjac M, Suleiman N, Ramanjaneya M, Jerobin J Front Endocrinol (Lausanne). 2023; 13:1024832.

PMID: 36876056 PMC: 9982120. DOI: 10.3389/fendo.2022.1024832.


Diabetic sarcopenia: metabolic and molecular appraisal.

Giha H, Alamin O, Sater M Acta Diabetol. 2022; 59(8):989-1000.

PMID: 35429264 DOI: 10.1007/s00592-022-01883-2.